Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03793478
Title Safety and Effectiveness of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Daiichi Sankyo, Inc.
Indications

acute myeloid leukemia

Therapies

Etoposide

Cytarabine + Fludarabine + Methotrexate + Prednisolone + Quizartinib

Cytarabine + Daunorubicin + Fludarabine + Methotrexate + Prednisolone + Quizartinib

Cytarabine + Daunorubicin + Fludarabine + Hydrocortisone + Methotrexate + Quizartinib

Cytarabine + Fludarabine + Methotrexate + Prednisolone

Quizartinib

Age Groups: adult | child
Covered Countries USA | CAN

Additional content available in CKB BOOST